Diffuse midline glioma, H3 K27-altered: genes and variants
Explore variant evidence for Diffuse midline glioma, H3 K27-altered across 1 analyzed protein (MUTYH). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 9 variants of uncertain significance and 1 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Diffuse midline glioma, H3 K27-altered
MUTYH: Adenine DNA glycosylase
It removes adenines incorrectly paired with oxidized guanine, preventing characteristic G:C-to-T:A mutations during base-excision repair. Biallelic loss-of-function variants cause MUTYH-associated polyposis and substantially increase colorectal-cancer risk.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MUTYH have source records linked to Diffuse midline glioma, H3 K27-altered. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): MSH3, NBN, BRAF, CHEK2, IDH1, MEN1, PALB2 and SMARCA4.
ClinVar pathogenic and likely pathogenic variants linked to Diffuse midline glioma, H3 K27-altered
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MUTYH R242H | 242 | Pathogenic / likely pathogenic (★★) | |
| MUTYH G393D | 393 | Nudix hydrolase | Pathogenic / likely pathogenic (★★) |
Same protein, different disease
- Familial adenomatous polyposis also has ClinVar records linked to MUTYH variants; they fall mostly in different places as the Diffuse midline glioma, H3 K27-altered variants (27 pathogenic / likely pathogenic).
- Gastric cancer also has ClinVar records linked to MUTYH variants; they fall mostly in different places as the Diffuse midline glioma, H3 K27-altered variants (11 pathogenic / likely pathogenic).
Diseases related to Diffuse midline glioma, H3 K27-altered
- Familial adenomatous polyposis, also linked to MUTYH
- Colorectal cancer, also linked to MUTYH
- Gastric cancer, also linked to MUTYH
- Colon carcinoma, also linked to MUTYH
- Pilomatrixoma, also linked to MUTYH
- Inherited polyposis and early onset colorectal cancer - germline testing, also linked to MUTYH
- Gastric neoplasm, also linked to MUTYH
- Familial colorectal cancer, also linked to MUTYH
- Classic or attenuated familial adenomatous polyposis, also linked to MUTYH
Frequently asked questions
Which genes have records linked to Diffuse midline glioma, H3 K27-altered?
This view contains 1 analyzed proteins: MUTYH. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 9 variants of uncertain significance and 1 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 12 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center